[Therapeutic contribution of the new quinolones].
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D001711:Biotransformation; D055598:Chemical Phenomena; D002621:Chemistry; D002939:Ciprofloxacin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007700:Kinetics; D009268:Nalidixic Acid / Q000627:therapeutic use; D009643:Norfloxacin / Q000031:analogs & derivatives / Q000627:therapeutic use; D015242:Ofloxacin; D010078:Oxazines / Q000627:therapeutic use; D015366:Pefloxacin
D000890:Anti-Infective Agents; D010078:Oxazines; D015366:Pefloxacin; D009268:Nalidixic Acid; D002939:Ciprofloxacin; D015242:Ofloxacin; D009643:Norfloxacin
Apport thérapeutique des nouvelles quinolones.